Gapping up
In reaction to strong earnings/guidance: ABMD +29.3%, (also receives FDA HDE approval for the Impella RP; First FDA Approved percutaneous single access heart pump designed for right heart support), FSL +14.3%, ZHNE +8.8%, AAPL +8.4%, X +8.4%, FTK +8.3%, WDC +6.5%, YHOO +5.4%, JNPR +5.4%, TUP +5.3%, KLIC +5.1%, EA +4.6%, ABC +4.3%, KTCC +3.9%, (thinly traded), TEL +3.7%, COMM +3.6%, ACAT +3.6%, BA +3.3%, MRCY +2.7%, SYMC +2.5%, UMC +2.4%, CNI +2.2%, (also increases quarterly dividend ), MTOR +2.2%, CYT +2%, ANTM +2%, GD +2%, TSS +1.9%, SPIL +1.8%, IP +1.5%, CRS +1.1%, T +1%, DOX +1%, (also enters into five-year managed services contract for business and operational support systems (B/OSS) with U.S. Cellular; selected by Telefonica for multi-channel transformation in Brazil), MRTN +0.8%
M&A news: RMTI +5.1% (cont M&A spec), COMM +3.6% (Commscope (COMM) confirms it has agreed to acquire TE Connectivity's Enterprise and Wireless businesses, also reported guidance), TEL +3.5% (Commscope (COMM) confirms it has agreed to acquire TE Connectivity's Enterprise and Wireless businesses; also reported earnings)
Select AAPL supplier/related names showing strength: CRUS +3.7%, SWKS +2.5%, NXPI +2.5%, BRCM +2.4%, QCOM +1.3%, AVGO +1.2%
Other news: APRI +46.7% (announced issuance of U.S. patent for RayVa), PSTI +12.5% (still checking), FTK +8.3% (to purchase substantially all of the assets of International Artificial Lift for $2.25 mln), ADXS +7.7% (update related to the Phase 2 open-label clinical study of ADXS-HPV), UIHC +5.1% (to replace AKRX in the S&P SmallCap 600), PLUG +3.1% (cont strength), AKS+2.6% (following X results and its own earnings Jan 27 before the open), ANIP +2.4% (to replace GTIV in the S&P SmallCap 600), LUV +2.4% (upgraded to Outperform from Neutral at Credit Suisse), REXX +2.3% (announced 2014 proved reserves increased 57% to 1,337 Bcfe), MTOR +2.2% (announces that it will launch a network of Meritor-approved repair shops with independent service garages across the United States and Canada ), MU +2% (in symp with JNPR, AAPL), STX +1.7% (following WDC earnings), FB +1.7% (trading higher with Nasdaq futures; will report AMC), ATVI +1.5% (following EA results), CPST +1.5% (may be in relation to order from Syracuse VA Medical Center for Eight C65 Microturbines announced yesterday), WLT +1.3% (suspends dividend; co previously paid a quarterly dividend of $0.01 per share), MPEL +1.3% (Macau table games revenue rose 6% last week), CVE +1.1% (to respond to low oil prices with capital budget reductions), AMZN +1% (trading higher with Nasdaq futures), GOOG +1% (trading higher with Nasdaq futures), SSL +0.9% (announces plan to respond to a low oil price environment)
Analyst comments: ACAD +2.5% (target raised to $50 from $42 at Jefferies), USG +1.7% (upgraded to Outperform from Neutral at Macquarie)
In reaction to strong earnings/guidance: ABMD +29.3%, (also receives FDA HDE approval for the Impella RP; First FDA Approved percutaneous single access heart pump designed for right heart support), FSL +14.3%, ZHNE +8.8%, AAPL +8.4%, X +8.4%, FTK +8.3%, WDC +6.5%, YHOO +5.4%, JNPR +5.4%, TUP +5.3%, KLIC +5.1%, EA +4.6%, ABC +4.3%, KTCC +3.9%, (thinly traded), TEL +3.7%, COMM +3.6%, ACAT +3.6%, BA +3.3%, MRCY +2.7%, SYMC +2.5%, UMC +2.4%, CNI +2.2%, (also increases quarterly dividend ), MTOR +2.2%, CYT +2%, ANTM +2%, GD +2%, TSS +1.9%, SPIL +1.8%, IP +1.5%, CRS +1.1%, T +1%, DOX +1%, (also enters into five-year managed services contract for business and operational support systems (B/OSS) with U.S. Cellular; selected by Telefonica for multi-channel transformation in Brazil), MRTN +0.8%
M&A news: RMTI +5.1% (cont M&A spec), COMM +3.6% (Commscope (COMM) confirms it has agreed to acquire TE Connectivity's Enterprise and Wireless businesses, also reported guidance), TEL +3.5% (Commscope (COMM) confirms it has agreed to acquire TE Connectivity's Enterprise and Wireless businesses; also reported earnings)
Select AAPL supplier/related names showing strength: CRUS +3.7%, SWKS +2.5%, NXPI +2.5%, BRCM +2.4%, QCOM +1.3%, AVGO +1.2%
Other news: APRI +46.7% (announced issuance of U.S. patent for RayVa), PSTI +12.5% (still checking), FTK +8.3% (to purchase substantially all of the assets of International Artificial Lift for $2.25 mln), ADXS +7.7% (update related to the Phase 2 open-label clinical study of ADXS-HPV), UIHC +5.1% (to replace AKRX in the S&P SmallCap 600), PLUG +3.1% (cont strength), AKS+2.6% (following X results and its own earnings Jan 27 before the open), ANIP +2.4% (to replace GTIV in the S&P SmallCap 600), LUV +2.4% (upgraded to Outperform from Neutral at Credit Suisse), REXX +2.3% (announced 2014 proved reserves increased 57% to 1,337 Bcfe), MTOR +2.2% (announces that it will launch a network of Meritor-approved repair shops with independent service garages across the United States and Canada ), MU +2% (in symp with JNPR, AAPL), STX +1.7% (following WDC earnings), FB +1.7% (trading higher with Nasdaq futures; will report AMC), ATVI +1.5% (following EA results), CPST +1.5% (may be in relation to order from Syracuse VA Medical Center for Eight C65 Microturbines announced yesterday), WLT +1.3% (suspends dividend; co previously paid a quarterly dividend of $0.01 per share), MPEL +1.3% (Macau table games revenue rose 6% last week), CVE +1.1% (to respond to low oil prices with capital budget reductions), AMZN +1% (trading higher with Nasdaq futures), GOOG +1% (trading higher with Nasdaq futures), SSL +0.9% (announces plan to respond to a low oil price environment)
Analyst comments: ACAD +2.5% (target raised to $50 from $42 at Jefferies), USG +1.7% (upgraded to Outperform from Neutral at Macquarie)